GlycoMimetics
GLYC
#10302
Rank
ยฃ7.5 M
Marketcap
ยฃ0.12
Share price
-5.42%
Change (1 day)
-39.05%
Change (1 year)

GlycoMimetics (GLYC) - Net assets

Net assets on the balance sheet as of March 2025 : ยฃ2.5 Million

According to GlycoMimetics 's latest financial reports the company has ยฃ2.5 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlycoMimetics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ4.23 M-85.96%
2023-12-31$ยฃ30.15 M-15.03%
2022-12-31$ยฃ35.48 M-41.3%
2021-12-31$ยฃ60.45 M-35.73%
2020-12-31$ยฃ94.06 M-20.01%
2019-12-31$ยฃ0.11 B-27.35%
2018-12-31$ยฃ0.16 B82.76%
2017-12-31$ยฃ88.56 M209.58%
2016-12-31$ยฃ28.6 M4.76%
2015-12-31$ยฃ27.31 M-16.31%
2014-12-31$ยฃ32.63 M1751.31%
2013-12-31$ยฃ1.76 M-77.26%
2012-12-31$ยฃ7.75 M42.46%
2011-12-31$ยฃ5.44 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
bluebird bio
BLUE
-ยฃ42.87 Million-1,814.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ68.95 B 2,758,095.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ63.92 B 2,556,664.68%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
ยฃ58.72 B 2,348,674.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ0.29 M-88.26%๐Ÿ‡บ๐Ÿ‡ธ USA